Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Marij J P Welters"'
Autor:
Diane van der Woude, Theo Rispens, Catharina M Korse, Sjoerd H van der Burg, Ellen Kapiteijn, John B A G Haanen, Winan J van Houdt, Els M E Verdegaal, Marij J P Welters, Jessica S W Borgers, Tineke J van Wesemael, Johannes V van Thienen, Kyra A Gelderman, Dirk J A R Moes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Introduction Treatment with the immune checkpoint inhibitor anti-programmed cell death protein-1 (PD-1) often causes immune-related adverse events (irAEs). Since irAEs resemble autoimmune diseases, autoantibodies might play a role and could potential
Externí odkaz:
https://doaj.org/article/9616b7f6fe8b499baab93acfee17c709
Autor:
Judith R Kroep, Sjoerd H van der Burg, Marten Visser, Linda de Bruin, Pauline Meij, Inge Roozen, Els M E Verdegaal, Caroline E van der Minne, Marij J P Welters, Saskia J Santegoets, Nikki M Loof, Sanne Boekestijn, Pita M de Kok, Inge M Westra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background The presence of T cells and suppressive myeloid cells in epithelial ovarian cancer (EOC) correlate with good and bad clinical outcome, respectively. This suggests that EOC may be sensitive to adoptive cell therapy with autologous tumor-inf
Externí odkaz:
https://doaj.org/article/23ac6018768843a28d87a7fb513a2cca
Autor:
Hans Gelderblom, Sjoerd H van der Burg, Ferry Ossendorp, Peggy J de Vos van Steenwijk, Mariette I E van Poelgeest, Inge Roozen, Willem-Jan Krebber, Cornelis J M Melief, Frank M Speetjens, Marij J P Welters, Nikki M Loof, Sanne Boekestijn, Catharina A H Janssen, Marije Slingerland, Gijs G Zom, A Rob P M Valentijn, Nico J Meeuwenoord, Gijs A van der Marel, Dmitri V Filippov
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Amplivant is a molecularly optimized Toll-like receptor 2 ligand that can be covalently conjugated to tumor peptide antigens. In preclinical models, amplivant-adjuvanted synthetic long peptides (SLPs) strongly enhanced antigen presentation
Externí odkaz:
https://doaj.org/article/116d0102ba984134b3b45409c8b1b84b
Autor:
Sjoerd H van der Burg, Thomas Höllt, Ziena Abdulrahman, Marieke E Ijsselsteijn, Noel F C C de Miranda, Dana A M Mustafa, Marij J P Welters, Zlatko Trajanoski, Saskia J Santegoets, Pornpimol Charoentong, Gregor Sturm, Antonios Somarakis, Francesca Finotello, Sylvia L van Egmond
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/f0029b590dda439cbaad7a04015bd7c8
Autor:
Sjoerd H van der Burg, Ramon Arens, Hubert Hackl, Ziena Abdulrahman, Ilina Ehsan, Mariette I E van Poelgeest, Marij J P Welters, Zlatko Trajanoski, Peter ten Dijke, Saskia J Santegoets, Gregor Sturm, Francesca Finotello, Chantal L Duurland, Nikki M Loof, Tom H Wesselink, Sanne Boekestijn, Veronique M Braud
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/03fe6d92883f4169a60a5722440cf6e5
Autor:
Joachim G J V Aerts, Ron H J Mathijssen, Mandy van Brakel, Ellen Kapiteijn, Daan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, Rik de Wijn, Lies Hovestad, Dianne M A van den Heuvel, Rob Ruijtenbeek, Marij J P Welters, Edwin A Basak, Herbert M Pinedo, Cor H J Lamers, Harmen J G van de Werken, John P Groten, Mitchell P Levesque
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Many cancer patients do not obtain clinical benefit from immune checkpoint inhibition. Checkpoint blockade targets T cells, suggesting that tyrosine kinase activity profiling of baseline peripheral blood mononuclear cells may predict clini
Externí odkaz:
https://doaj.org/article/fdec7b4cc229438683584ce62dfcc0e3
Autor:
Wenbo Ma, Fernando Concha-Benavente, Saskia J A M Santegoets, Marij J P Welters, Ilina Ehsan, Robert L Ferris, Sjoerd H van der Burg
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203402 (2018)
Resistance to antitumor immunity can be promoted by the oncogenic pathways operational in human cancers, including the epidermal growth factor receptor (EGFR) pathway. Here we studied if and how EGFR downstream signaling in head and neck squamous cel
Externí odkaz:
https://doaj.org/article/db138445007840f8b7a93e9a954efa94
Autor:
Andrew Cron, Cécile Gouttefangeas, Jacob Frelinger, Lin Lin, Satwinder K Singh, Cedrik M Britten, Marij J P Welters, Sjoerd H van der Burg, Mike West, Cliburn Chan
Publikováno v:
PLoS Computational Biology, Vol 9, Iss 7, p e1003130 (2013)
Flow cytometry is the prototypical assay for multi-parameter single cell analysis, and is essential in vaccine and biomarker research for the enumeration of antigen-specific lymphocytes that are often found in extremely low frequencies (0.1% or less)
Externí odkaz:
https://doaj.org/article/06513624c96542608300c537b0a8b6af
Autor:
Anna Paaso, Hanna‐Mari Koskimaa, Marij J. P. Welters, Katja Kero, Jaana Rautava, Kari Syrjänen, Sjoerd H. van derBurg, Stina Syrjänen
Publikováno v:
Clinical and Experimental Dental Research, Vol 7, Iss 5, Pp 903-913 (2021)
Objectives Natural history of human papillomavirus (HPV) infection in the head and neck region is poorly understood, and their impact on collective HPV‐specific immunity is not known. Materials and methods In this study, we have performed a systema
Autor:
Janine E. Melsen, Monique M. van Ostaijen-ten Dam, Erik B. van den Akker, Marij J. P. Welters, Kim C. Heezen, Ingrid Pico-Knijnenburg, P. Martijn Kolijn, Robbert G. M. Bredius, Remco van Doorn, Anton W. Langerak, Marco W. Schilham, Arjan C. Lankester
Publikováno v:
Journal of Clinical Immunology. SPRINGER/PLENUM PUBLISHERS
Journal of Clinical Immunology
Journal of Clinical Immunology, 42(6)
Journal of Clinical Immunology, 42(6), 1205-1222. Springer New York
Journal of Clinical Immunology
Journal of Clinical Immunology, 42(6)
Journal of Clinical Immunology, 42(6), 1205-1222. Springer New York
The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c140ea0447ee391ac04b7a281a5a13c7
https://hdl.handle.net/1887/3561418
https://hdl.handle.net/1887/3561418